FDA recall D-0266-2025 · initiated Mar 4, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.